Duolab, the skin care tech brand developed by the L’Occitane Group, has relaunched its e-commerce website, including a skin diagnosis tool.
The new feature provides personalised skin care formulations for consumers and was developed in partnership with Revive, a specialist in self-diagnostic modules.
Duolab’s beauty system, launched to consumers in 2020, includes a countertop Lab Device that blends 20 different face care formulations via an assortment of mix-and-match capsules.
The freshly-blended personalised serums and moisturisers are preservative free and are claimed to be rich in natural active ingredients.
“Adapting and tailoring a flexible skin care routine for each individual person is what Duolab is all about,” said Duolab’s Managing Director Alain Harfouche.
“So, of course, the most important first step is to identify the customer’s personal needs: their skin type, their goals, their lifestyle and their preferences.
“By working with Revieve we are able to combine consumers’ own observations with smart AI technology that analyses multiple aspects of their skin and recommends a tailored ‘prescription’ to deliver on their needs.”
Revieve's computer vision technology measures more than 120 skin metrics to provide users with an in-depth analysis of their skin.
First-time customers begin with an online skin diagnosis on Duolab’s website, answering questions about their skin concerns and personal needs.
They input their geographical location and upload a selfie image.
After analysis, the tool recommends a tailored ‘prescription’ of capsule combinations to answer the customer’s needs.
Duolab plans to introduce a ‘Skin Coach’ module to help consumers track their progress over time (and amend their routine if needed) later this year.
“Personalised and customised skin care is no longer just an option for customers; it's the norm," said Sampo Parkkinen, CEO of Revieve.
“The future will be about educating consumers about their skin and helping them achieve the best skin of their life and the confidence that comes with it.”
